Kamalika Roy, MD, MCR

As a board-certified consultation-liaison psychiatrist, I love working with people with cancer or other complex medical problems, including but not limited to neurodegenerative disorders, sleep disorders, delirium, and catatonia. It is crucial to treat and support psychiatric conditions often associated with multiple disease processes and treatment complications. As a member of the psycho-oncology team at Fred Hutchinson Cancer Center, I enjoy the opportunity to collaborate with various specialties to help my patients during the most stressful times of their overall care.  I have expertise in diagnosis, psychopharmacology, psychotherapy, and electroconvulsive therapy. I conducted clinical research in pharmacogenomics, delirium, and pre-dementia cognitive impairment in the past. I strongly believe in shared decision-making in the process of treatment.

Education

Masters in Clinical Research, Oregon Health & Science University, Portland, OR, 2020
Fellowship,Consultation-Liaison Psychiatry, University of Michigan, Ann Arbor, 2017
Residency, Wayne State University, Detroit, Michigan, 2016

Other Affiliations

Fred Hutchinson Cancer Center

Recent Publications

High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.
(2023)
Front Immunol 14(): 1303959
Dhar S, Chakravarti M, Ganguly N, Saha A, Dasgupta S, Bera S, Sarkar A, Roy K, Das J, Bhuniya A, Ghosh S, Sarkar M, Hajra S, Banerjee S, Pal C, Saha B, Mukherjee KK, Baral R, Bose A

Geriatric Cognitive Decline and Polypharmacy.
(2024 Jan)

Chippa V, Roy K

Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells.
(2023 Jun 2)
Cancer Res 83(11): 1815-1833
Chakravarti M, Dhar S, Bera S, Sinha A, Roy K, Sarkar A, Dasgupta S, Bhuniya A, Saha A, Das J, Banerjee S, Vernekar M, Pal C, Alam N, Datta D, Baral R, Bose A

TLR induced IL-27 plays host-protective role against B16BL6 melanoma in C57BL/6 mice.
(2022 Jun)
Cytokine 154(): 155871
Patidar A, Selvaraj S, Chakravarti M, Guha I, Bhuniya A, Bera S, Dhar S, Roy K, Baral R, Chattopadhyay D, Pal C, Saha B

NLGP regulates RGS5-TGFβ axis to promote pericyte-dependent vascular normalization during restricted tumor growth.
(2022 May)
FASEB J 36(5): e22268
Dasgupta S, Saha A, Ganguly N, Bhuniya A, Dhar S, Guha I, Ghosh T, Sarkar A, Ghosh S, Roy K, Das T, Banerjee S, Pal C, Baral R, Bose A

Show complete publication list »
Edit Profile